In this prognostic signature, DBT, FDX1, LIPT1, and PDHA1 acted as positive predictors, while ATP7A, DLAT, and GCSH acted as negative predictors for survival in CC patients. This evidence concerns the gene DLAT and cholangiocarcinoma.